Estadisticas : Comparative Analysis of 2 Commercially Available Assays for Therapeutic Drug Monitoring of Infliximab and Adalimumab

López Pérez, Juan
Visitas:282

161 ( Estados Unidos de América )

49 ( Singapur )

11 ( Brasil )

11 ( Reino Unido )

9 ( Hong kong )

5 ( Alemania )

5 ( México )

4 ( Francia )

3 ( Lituania )

3 ( Arabia Saudita )

2 ( Finlandia )

2 ( Polonia )

2 ( China )

2 ( Argentina )

2 ( Austria )

2 ( India )

2 ( España )

1 ( Bangladesh )

1 ( Rusia )

1 ( Turquía )

1 ( Letonia )

1 ( Azerbaiyán )

1 ( Suecia )

1 ( Israel )

Descargas: 0